Please use this identifier to cite or link to this item: https://doi.org/10.1158/1535-7163.MCT-14-0485
Title: A preclinical evaluation of SKLB261
a multikinase inhibitor of EGFR/Src/VEGFR2
as a therapeutic agent against pancreatic cancer
Authors: Li L.
Lyu X.
Hou C.
Takenaka N.
Nguyen H.Q.
Ong C.-T. 
Cubenas-Potts C.
Hu M.
Lei E.P.
Bosco G.
Qin Z.S.
Corces V.G.
Issue Date: 2015
Publisher: American Association for Cancer Research Inc.
Citation: Li L., Lyu X., Hou C., Takenaka N., Nguyen H.Q., Ong C.-T., Cubenas-Potts C., Hu M., Lei E.P., Bosco G., Qin Z.S., Corces V.G. (2015). A preclinical evaluation of SKLB261. Molecular Cancer Therapeutics 14 (2) : 407-418. ScholarBank@NUS Repository. https://doi.org/10.1158/1535-7163.MCT-14-0485
Source Title: Molecular Cancer Therapeutics
URI: http://scholarbank.nus.edu.sg/handle/10635/127648
ISSN: 15357163
DOI: 10.1158/1535-7163.MCT-14-0485
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

14
checked on Sep 18, 2018

WEB OF SCIENCETM
Citations

15
checked on Sep 3, 2018

Page view(s)

26
checked on Sep 13, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.